nifuratel has been researched along with Vaginal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magnani, P; Mendling, W; Poli, A | 1 |
| Brundu, B; Fantuzzi, M; Frisenda, L; Nappi, RE; Polatti, F | 1 |
| Mailland, F; Mendling, W | 1 |
1 review(s) available for nifuratel and Vaginal Diseases
| Article | Year |
|---|---|
Clinical effects of nifuratel in vulvovaginal infections. A meta-analysis of metronidazole-controlled trials.
Topics: Antifungal Agents; Antitrichomonal Agents; Female; Humans; Metronidazole; Nifuratel; Randomized Controlled Trials as Topic; Vaginal Diseases | 2002 |
1 trial(s) available for nifuratel and Vaginal Diseases
| Article | Year |
|---|---|
Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Middle Aged; Mycoses; Nifuratel; Nystatin; Treatment Outcome; Trichomonas Vaginitis; Vaginal Diseases | 2003 |
1 other study(ies) available for nifuratel and Vaginal Diseases
| Article | Year |
|---|---|
Microbiological and pharmaco-toxicological profile of nifuratel and its favourable risk/benefit ratio for the treatment of vulvo-vaginal infections. A review.
Topics: Animals; Antifungal Agents; Bacteria; Drug Resistance, Microbial; Female; Fungi; Humans; Nifuratel; Risk Assessment; Vaginal Diseases | 2002 |